Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer

Stopped early · Phase 2

Conditions studied: Prostate Cancer

In brief

The purpose of this research is to determine the effectiveness of CGC-11047 in subjects with metastatic hormone refractory prostate cancer as measured by changes in PSA.

Key facts

Study ID
NCT00585416
Run by
University of Wisconsin, Madison
People needed
23
Starts
2006-06-01
Expected to finish
2009-03-01
Last updated by the study team
2015-10-02

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.